Immediate Impact
50 standout
Citing Papers
AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
Works of Kiyean Nam being referenced
Abstract 2255: Patient pharmacodynamic biomarker and pk evaluation results from an ongoing phase I dose-escalation study of q702, an axl, mer and csf1r kinase inhibitor in patients with advanced solid tumors
2023
Abstract 4139: Q702, selective Axl, Mer and CSF1R triple kinase inhibitor with dual potentials leading to tumor regression: Immuno-oncology therapy and targeted cancer therapy
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kiyean Nam | 233 | 141 | 42 | 116 | 24 | 445 | |
| Alessandra Pasquali | 126 | 57 | 83 | 110 | 15 | 483 | |
| Adrien Herlédan | 254 | 44 | 60 | 50 | 19 | 432 | |
| Gábor Németh | 193 | 68 | 40 | 174 | 30 | 496 | |
| Peter J. Webb | 167 | 109 | 35 | 92 | 17 | 451 | |
| Michael Plewe | 379 | 58 | 43 | 92 | 16 | 503 | |
| Martine Hamel | 155 | 94 | 15 | 79 | 12 | 419 | |
| Stefano Sainas | 256 | 110 | 21 | 98 | 22 | 425 | |
| Terence Beghyn | 276 | 33 | 64 | 119 | 15 | 459 | |
| Chetan Chintha | 193 | 35 | 48 | 57 | 16 | 384 | |
| Рубен Карапетян | 233 | 37 | 35 | 91 | 28 | 438 |
All Works
Loading papers...